Alcolase is developing a liposomal enzyme system designed to support alcohol metabolism in the stomach. Copenhagen-based biotech backed by Ada Ventures and Delphinus Venture Capital.
Location: Denmark
Total raised: $1.75M
Founded date: 2021
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.05.2026 | - | $1.75M | Ada Ventur... |
Mentions in press and media 5
| Date | Title | Description |
| 18.05.2026 | Alcolase: €1.5 Million Raised For Enzyme-Based Remedy Addressing Alcohol Intolerance | Ada Ventures announced it has co-led a €1.5 million funding round into Danish-British biotech company Alcolase, which is developing what it describes as the world’s first enzyme system designed to break down alcohol in the stomach before it... |
| 18.05.2026 | Danish biotech Alcolase raises $1.7m to tackle alcohol intolerance, eyes SG entry | - |
| 17.05.2026 | Alcolase raises €1.5M to tackle alcohol intolerance with enzyme technology | Danish biotech startup Alcolase has raised €1.5 million with investment from Ada Ventures, Delphinus Venture Capital, Antler, Manigoff Invest and a group of business angels. Alcolase is developing an enzyme-based technology designed to brea... |
| - | Alcolase | “Alcolase is a danish startup who develops the world's first enzyme system breaking down alcohol in the stomach (before it enters the blood).” |
| - | Alcolase | “Welcome to Alcolase, a Danish life science start-up focusing on alcohol flush, founded by students from DTU and UCPH” |